Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes that ALD-102 Solution is being studied in Phase 1/2 to evaluate safety, tolerability, pharmacokinetics, and preliminary efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• ALD-102 Solution

Snippet

Sponsor: Aldena Therapeutics | Conditions: Alopecia Areata (AA) | Phase 1, Phase 2 | Status: RECRUITING